Show simple item record

dc.contributor.authorTajalli, M.
dc.contributor.authorKabir, S.
dc.contributor.authorVance, T.M.
dc.date.accessioned2020-03-10T19:46:46Z
dc.date.available2020-03-10T19:46:46Z
dc.date.issued2020
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85080146525&doi=10.1002%2fccr3.2759&partnerID=40&md5=217ff4e005798d693f6bb51ae3b1cff7
dc.identifier.urihttp://hdl.handle.net/10713/12179
dc.description.abstractThis case presentation suggests that tofacitinib combined with phototherapy may be an effective treatment option for patients with concomitant alopecia areata, vitiligo, and different phenotypes of psoriasis including plaque and inverse psoriasis. Copyright 2020 The Authors.en_US
dc.description.urihttps://doi.org/10.1002/ccr3.2759en_US
dc.language.isoen_USen_US
dc.publisherWiley-Blackwell Publishing Ltden_US
dc.relation.ispartofClinical Case Reports
dc.subjectalopecia areataen_US
dc.subjectinverse psoriasisen_US
dc.subjectphototherapyen_US
dc.subjectplaque psoriasisen_US
dc.subjecttofacitiniben_US
dc.subjectvitiligoen_US
dc.titleEffective use of oral tofacitinib and phototherapy in a patient with concomitant alopecia areata, vitiligo, and plaque and inverse psoriasisen_US
dc.typeArticleen_US
dc.identifier.doi10.1002/ccr3.2759


This item appears in the following Collection(s)

Show simple item record